Please assess the completion status of the following clinical trial:

Trial Title: Renal Denervation for Complicated Hypertension

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* BP ≥140/90 mmHg (or ≥130/80 mmHg for patients with diabetes)~* Intolerance to ≥2 antihypertensive drug classes~* Inability to take Angiotensin-Converting-Enzyme Inhibitor (ACEI), Angiotensin II Receptor Blockers (ARBs) or Direct Renin inhibitors (DRIs) due to planned pregnancy~* Renal artery stenosis~* Chronic Kidney Disease~Exclusion Criteria:~* renal artery anatomy ineligible for treatment~* individual has had myocardial infarction, unstable angina or cerebrovascular accident within 6 months of screening visit~* female participants of childbearing potential must have negative pregnancy test prior to treatment

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Renal Denervation (Type: EXPERIMENTAL): Renal Denervation treatment

Based on this trial design, predict the completion outcome and termination type (if applicable).